Yubo Tang

1.9k total citations
49 papers, 1.6k citations indexed

About

Yubo Tang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yubo Tang has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Yubo Tang's work include MicroRNA in disease regulation (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yubo Tang is often cited by papers focused on MicroRNA in disease regulation (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer-related molecular mechanisms research (7 papers). Yubo Tang collaborates with scholars based in China, Germany and United States. Yubo Tang's co-authors include Xuenong Zou, Shuai Huang, Xinsheng Peng, Dong Ren, Angela Jacobi, Maik Stiehler, Corina Vater, Weitong Huang, Qingde Wa and Wei Guo and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and PLoS ONE.

In The Last Decade

Yubo Tang

45 papers receiving 1.6k citations

Peers

Yubo Tang
Yubo Tang
Citations per year, relative to Yubo Tang Yubo Tang (= 1×) peers Minfeng Chen

Countries citing papers authored by Yubo Tang

Since Specialization
Citations

This map shows the geographic impact of Yubo Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Tang more than expected).

Fields of papers citing papers by Yubo Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubo Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Tang. The network helps show where Yubo Tang may publish in the future.

Co-authorship network of co-authors of Yubo Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yubo Tang. A scholar is included among the top collaborators of Yubo Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubo Tang. Yubo Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jia, Yubo Tang, Xiao Chen, et al.. (2024). H3K27ac acts as a molecular switch for doxorubicin-induced activation of cardiotoxic genes. Clinical Epigenetics. 16(1). 91–91. 3 indexed citations
2.
Dong, Yang, et al.. (2024). A DNA-inspired injectable adhesive hydrogel with dual nitric oxide donors to promote angiogenesis for enhanced wound healing. Acta Biomaterialia. 176. 128–143. 35 indexed citations
3.
Sun, Lu, Min Gao, Kaimin Guo, et al.. (2024). ClC-5 knockout mitigates angiotensin II-induced hypertension and endothelial dysfunction. Life Sciences. 362. 123342–123342. 1 indexed citations
5.
Yang, Sheng, Yubo Tang, Yijun Liu, et al.. (2022). Arf GTPase activates the WAVE regulatory complex through a distinct binding site. Science Advances. 8(50). eadd1412–eadd1412. 14 indexed citations
6.
Tang, Yubo, Qingde Wa, Longyun Peng, et al.. (2022). Salvianolic Acid B Suppresses ER Stress‐Induced NLRP3 Inflammasome and Pyroptosis via the AMPK/FoxO4 and Syndecan‐4/Rac1 Signaling Pathways in Human Endothelial Progenitor Cells. Oxidative Medicine and Cellular Longevity. 2022(1). 8332825–8332825. 36 indexed citations
7.
Zheng, Yifan, Yan Tang, Tao-Hsing Chang, et al.. (2022). Evaluation of quality and readability of over-the-counter medication package inserts. Research in Social and Administrative Pharmacy. 18(9). 3560–3567. 5 indexed citations
8.
Tang, Yubo, et al.. (2022). Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer. Reproductive Sciences. 30(6). 2003–2015. 3 indexed citations
9.
Tang, Feng, Wei Shi, Yang Yang, et al.. (2020). Selective N-glycan editing on living cell surfaces to probe glycoconjugate function. Nature Chemical Biology. 16(7). 766–775. 44 indexed citations
10.
Shi, Wei, Lei Zhao, Mingjie Li, et al.. (2019). Thermostability detection and optimization of glycoengineered antibodies and antibody-drug conjugates based on differential scanning flouremitry analysis. Bioorganic Chemistry. 94. 103391–103391. 12 indexed citations
11.
Wa, Qingde, Sheng Huang, Jincheng Pan, et al.. (2019). miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Molecular Therapy — Nucleic Acids. 18. 567–579. 49 indexed citations
12.
Qian, Jing, Xiaohong Xu, Yubo Tang, et al.. (2018). Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection. Veterinary Microbiology. 223. 9–20. 19 indexed citations
14.
Tang, Yubo, Feng Tang, Yang Yang, et al.. (2017). Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control. Scientific Reports. 7(1). 7763–7763. 68 indexed citations
15.
Kuchta, Kenny, Yucheng Xiang, Shuai Huang, et al.. (2017). Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. Prostate Cancer and Prostatic Diseases. 20(2). 156–164. 42 indexed citations
16.
Huang, Shuai, Yuanqing Guo, Angela Jacobi, et al.. (2016). Aromatic Hydrocarbon Receptor Suppresses Prostate Cancer Bone Metastasis Cells-Induced Vasculogenesis of Endothelial Progenitor Cells under Hypoxia. Cellular Physiology and Biochemistry. 39(2). 709–720. 7 indexed citations
17.
Huang, Shuai, Peiheng He, Xinsheng Peng, et al.. (2015). Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs. Cellular Physiology and Biochemistry. 37(1). 253–268. 35 indexed citations
18.
Tang, Yubo, Angela Jacobi, Corina Vater, Xuenong Zou, & Maik Stiehler. (2014). Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways. Biochemical Pharmacology. 90(1). 34–49. 75 indexed citations
19.
Huang, Shuai, Yubo Tang, Xingdong Cai, et al.. (2012). Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells. Biochemical and Biophysical Research Communications. 423(3). 467–472. 35 indexed citations
20.
Huang, Shuai, Wei Guo, Yubo Tang, et al.. (2012). miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. Oncology Reports. 28(5). 1831–1837. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026